Speciality Medicines Limited Sets March 20 for Strategic IPO Launch
Speciality Medicines Limited has officially announced its initial public offering (IPO) scheduled to open on March 20, 2026. This capital raise marks a critical expansion phase for the pharmaceutical firm as it targets high-growth segments in complex and niche therapeutic markets.